Risk* of late pulmonary toxicity other than pulmonary embolus after four courses of BEP in the Danish Testicular Cancer Registry series

Toxicity	BEP (n = 565)	No BEP (n = 2548)
Pulmonary fibrosis	3 (0.4%)	5 (0.2%)
Obstructive pulmonary disease	15 (3.3%)	72 (2.8%)
Pneumonia	15 (2.6%)	103 (3.3%)
Pneumothorax	2 (0.3%)	6 (0.4%)

BEP: bleomycin, etoposide, cisplatin.
* 15-year cumulative risk, with time at risk calculated one year from the treatment start.

From: Lauritsen J, Kier MG, Bandak M, et al. Pulmonary function in patients with germ cell cancer treated With Bleomycin, Etoposide, and Cisplatin. J Clin Oncol 2016; 34(13):1492-9. Reprinted with permission. Copyright © 2016 American Society of Clinical Oncology. All rights reserved.

Graphic 107640 Version 4.0

خرید پکیج

Risk* of late pulmonary toxicity other than pulmonary embolus after four courses of BEP in the Danish Testicular Cancer Registry series